$298,000
$330,000
a year
... Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of ... geographic atrophy, we are rigorously advancing our mid-to late-stage ... -making. Preferred: An MBA or advanced degree is strongly preferred. Salary ...
2 days ago
$228,000
$255,000
a year
... Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of ... geographic atrophy, we are rigorously advancing our mid-to late-stage ...
2 days ago